โจทย์ ปรนัย
What is the primary goal of the article according to its introduction?

The introduction of the article clearly states that its main goal is to provide an overview of generative AI in medical imaging, covering recent technological advancements, practical applications in healthcare, and associated challenges such as ethics, regulation, and data limitations. It does not focus on hospital management, economic analysis, policy comparison, or designing new models, but rather on summarizing the state of generative AI in medical imaging.

The article frames this goal in line with common scientific review objectives: summarizing current knowledge, highlighting clinical and research applications, and discussing future directions and regulatory considerations. This approach is consistent with review articles in journals, which aim to synthesize emerging AI trends in healthcare rather than present novel algorithms or economic studies.

โจทย์ ปรนัย
How do generative AI models differ from traditional discriminative models in healthcare applications?

Traditional discriminative models focus on recognizing or classifying existing data, such as detecting disease in an X-ray. Generative models, however, can create new medical images or patient data that look realistic, which helps with training, research, and improving diagnostic tools.

Discriminative models learn to tell categories apart (like healthy vs. diseased), while generative models learn how data are formed so they can create new examples. Generative AI can simulate medical data, making it useful for healthcare innovation and data-driven studies.

โจทย์ ปรนัย
What is meant by the term “model as a dataset”?

Real patient data is private and hard to share, so instead of giving others the raw data (like patient images or records), researchers can share the model weights. These weights contain useful information about patterns in the data but don't reveal personal details directly. This allows collaboration and innovation while protecting patient privacy.

The model's weight acts as like a summery for the dataset. In theory, we can share this model (with all of It's knowledge/data) without sharing sensitive data of patients. This concept helps support data privacy and collaborations between hospitals and researchers.

โจทย์ ปรนัย
Which statement correctly distinguishes physics-informed and statistical models?

Physics-informed use real physical or biological principles such as Newton's law, the conservation of energy, etc. It is used to guide the model how to learn or predict results. It combines data with scientific rules, so their predictions stay realistic and consistent with nature. Statistical models rely mainly on patterns found in data without using physical or biological laws. They can make predictions but may produce results that are not physically possible if the data is limited or noisy.

Physics-informed models combine data-driven learning with equations from physics or biology like F=ma, diffusion laws, and heat equations. Statistical models finds relationship between variables, like correlation and regression, only from data. It doesn’t use real-world laws and depends heavily on data quality.

โจทย์ ปรนัย
According to the article, what does the “image generation trilemma” describe?

Image generation trilemma is used to describe the challenge in synthetic image generation of simultaneously achieving: high diversity (covering different patient anatomies, disease variants, etc.), high quality (realistic, accurate images), fast/efficient generation (reasonable computational cost/latency)

Because data is scarce and real images are expensive and hard to get, image generation is critical for clinical workflows. The problem of image generation is these 3 factors: diversity, quality, and speed. And when improving one it often degrades another hence the term "trilemma".

โจทย์ ปรนัย
What is the Human Turing Test used for in medical image synthesis?

The Human Turing Test is to see if AI-generated images can fool humans. Sets of real and synthetic images are gathered, and experts are asked to distinguish which is real or which is fake, If the experts cannot reliably distinguish the synthetic images from real ones, the synthetic images are considered highly realistic.

The test is based on Alan Turing’s original idea, which checks if a machine can imitate human behavior. applying this to medical imaging, the focus is visual realism rather than conversation. The principle is that human judgment is the gold standard for assessing whether AI-generated images are realistic. This method is important in healthcare because realistic synthetic images can be safely used for training AI models, research, or educational purposes without exposing real patient data.

โจทย์ ปรนัย
Which of the following is NOT mentioned as a potential benefit of synthetic data in healthcare?

Synthetic data in healthcare can enhance data diversity, preserve patient privacy, facilitate multi-center collaborations, and support medical education, but it cannot permanently eliminate medical biases, because biases in the original datasets can still appear or even be amplified in the generated data.

Synthetic data is created by AI models that mimic real medical data, allowing safe sharing and flexible use without exposing patient information. While it supports privacy, diversity, and collaboration, bias reduction is not automatic and requires careful dataset design and evaluation

โจทย์ ปรนัย
What is one major ethical concern associated with generative AI in medical imaging?

A major ethical concern with generative AI in medical imaging is that models may inadvertently copy parts of real patient data or generate images that are too similar to the originals, creating a risk of patient reidentification. This threatens privacy and can violate regulations, even when synthetic images are intended to be anonymized.

Generative models learn patterns from real datasets, and without careful safeguards, they can memorize sensitive data. Ethical guidelines in medical AI emphasize that models must protect patient privacy and prevent unintentional leakage of identifiable information.

โจทย์ ปรนัย
What regulatory precedent did the article cite for synthetic data technologies?

The article mentions that a regulatory milestone was achieved when the FDA cleared a software tool for synthetic MRI, treating it as a medical image‑processing device rather than raw synthetic data alone. This clearance serves as a precedent for how synthetic data and synthetic imaging technologies may be regulated within healthcare.

This regulatory example is grounded in device‑clearance frameworks, specifically the FDA’s 510(k) pathway for devices that are substantially equivalent to earlier devices. The synthetic MRI tool received 510(k) clearance as a Class II device, indicating that regulators treat synthetic image‑generation and processing tools similarly to other medical image‑processing devices.

โจทย์ ปรนัย
What is the main purpose of the article?

The figure and context focus on cardiovascular disease (CVD) mortality rates among East Asian countries. This indicates that the article’s goal is to examine and compare CVD or ASCVD (atherosclerotic cardiovascular disease) risk and model performance within this regional population rather than developing new models for Western countries or studying genetics or imaging technologies.

Comparative epidemiological studies use regional data to evaluate the accuracy and applicability of existing ASCVD risk prediction models. Localized validation is essential because risk factors and population characteristics vary by ethnicity, lifestyle, and healthcare systems. Therefore, assessing and comparing models across East Asian populations helps improve prediction accuracy and public health policy relevance.

โจทย์ ปรนัย
Which of the following models was originally developed for a Western population?

The Framingham Risk Score was originally developed based on data from the Framingham Heart Study, which tracked a predominantly Western population to estimate cardiovascular risk. In contrast, models like the China-PAR, Suita, KRPM, and NIPPON Data80 were developed for Asian populations to account for regional differences in risk factors and disease prevalence.

The Framingham Risk Score uses statistical regression models to predict 10-year risk of cardiovascular events based on factors like age, sex, blood pressure, cholesterol, and smoking status. Its development reflects the principle of population-specific risk modeling, emphasizing that models derived from one population may not generalize to others without recalibration.

โจทย์ ปรนัย
Why might Western-based risk prediction models overestimate ASCVD risk in East Asian populations?

Western-based risk prediction models, like the Framingham Risk Score, often overestimate ASCVD risk in East Asian populations because these populations generally have a lower baseline incidence of ASCVD. Applying risk equations derived from higher-risk Western cohorts can therefore predict more events than actually occur in East Asian patients, leading to potential overtreatment or unnecessary interventions.

Risk prediction models estimate absolute event probabilities using population-specific incidence and regression coefficients for risk factors. When applied to a population with lower baseline event rates, the same coefficients produce inflated predicted risks. This principle is consistent with population-specific calibration in cardiovascular epidemiology.

โจทย์ ปรนัย
What is the key advantage of the China-PAR model compared to Western-based models?

The China-PAR model’s key advantage is that it is specifically calibrated for the Chinese population using large, nationally representative datasets from multiple regions. This ensures that the predicted ASCVD risk accurately reflects local population characteristics, unlike Western-based models which may overestimate risk when applied to East Asians due to differences in baseline incidence and risk factor distribution.

Risk prediction models are most accurate when they are derived or recalibrated using data from the target population, incorporating local prevalence of risk factors and disease incidence. The China-PAR model uses statistical regression based on longitudinal cohort data across China, which improves prediction accuracy and clinical relevance.

โจทย์ ปรนัย
Which of the following variables is not typically included in ASCVD risk prediction models discussed in the article?

ASCVD risk prediction models such as Framingham, China-PAR, and Suita generally use variables like age, blood pressure, serum cholesterol, and smoking status to estimate 10-year cardiovascular risk. Genetic ancestry markers are not typically included in these traditional clinical models, as they rely on readily measured clinical and lifestyle factors rather than genomic data.

These models are based on statistical regression linking measurable risk factors to observed ASCVD events in population cohorts. Inclusion of variables is guided by predictive value, availability, and ease of measurement. While genetics can influence cardiovascular risk, current widely used risk scores do not incorporate ancestry markers, focusing instead on modifiable and non-modifiable clinical risk factors.

โจทย์ ปรนัย
What is a major difference between the Suita Score and the Framingham Risk Score?

The Suita Score differs from the Framingham Risk Score because it was specifically developed for a Japanese population using local cohort data to reflect the incidence and risk factor distribution in Japan. In contrast, the Framingham model was developed from a Western population, which can lead to overestimation of ASCVD risk when applied to East Asians.

Risk prediction models perform best when calibrated to the target population. The Suita Score uses statistical regression on Japanese cohort data, incorporating factors like age, blood pressure, cholesterol, and smoking, ensuring accurate prediction for Japanese adults. This population-specific approach aligns with the principle that baseline disease incidence and risk factor prevalence vary across populations.

โจทย์ ปรนัย
According to the article, what is a potential benefit of developing East Asia–specific risk models?

Developing East Asia–specific risk models allows cardiovascular risk prediction to reflect local population characteristics, including lower baseline ASCVD incidence and region-specific risk factor profiles. This reduces the overestimation of risk that occurs when Western-based models are applied to East Asian populations, resulting in more accurate and clinically relevant predictions.

Risk prediction models are calibrated using population-specific epidemiological data to match local disease incidence and risk factor distribution. Applying models derived from one population to another without adjustment can lead to systematic bias in predicted probabilities. East Asia–specific models use statistical regression on local cohort data to improve prediction accuracy, consistent with principles of population-specific model calibration.

โจทย์ ปรนัย
Which factor was highlighted as influencing ASCVD risk differences among East Asian countries?

The article highlights that differences in ASCVD risk among East Asian countries are influenced by cultural and dietary factors, such as variations in salt consumption, traditional diets, and lifestyle habits. These factors affect blood pressure, cholesterol, and overall cardiovascular health, leading to differences in disease prevalence and risk across regions.

Population-specific risk modeling considers environmental, lifestyle, and dietary influences on cardiovascular disease. Epidemiological studies show that high salt intake, sedentary lifestyle, and regional dietary patterns contribute to variability in ASCVD incidence. Models like China-PAR, Suita, and KRPM incorporate local cohort data to account for these differences, improving predictive accuracy for East Asian populations.

โจทย์ ปรนัย
What future direction does the article suggest for improving ASCVD risk prediction?

The article suggests that future improvements in ASCVD risk prediction should involve multimodal AI models that combine clinical measurements, imaging, lab results, and lifestyle or environmental data. Integrating regional population data allows the models to account for local variations in risk factors, improving prediction accuracy beyond traditional risk scores.

Multimodal AI leverages machine learning algorithms to process heterogeneous data sources, capturing complex interactions among risk factors. Combining regional epidemiological data with clinical and imaging inputs ensures models are population-calibrated and reflect local disease incidence, consistent with principles of precision medicine and predictive modeling.

โจทย์ ปรนัย
Which statement best explains the key difference in how VAEs, GANs, and DDPMs generate medical images according to the figure?

VAEs use an encoder–decoder architecture to reconstruct images from latent representations, and GANs use a generator–discriminator setup to distinguish real from fake images. DDPMs generate images by gradually removing noise through a reverse diffusion process, without using adversarial feedback or encoder–decoder components.

VAEs are based on probabilistic encoding and decoding, GANs rely on adversarial training using a min–max optimization between generator and discriminator, while DDPMs use a Markov chain process to add and then remove noise iteratively for image generation.

โจทย์ ปรนัย
Which of the following best explains the trend shown in Figure comparing age-standardized and crude CVD mortality rates among East Asian countries?

The figure shows that Japan and South Korea have much lower CVD mortality rates compared to Mongolia and North Korea in both age-standardized and crude measures. This indicates that their low mortality is not just due to a younger population but also to strong healthcare systems, early detection, and effective public health interventions targeting cardiovascular risk factors.

Age-standardized mortality adjusts for differences in population age structure to allow fair comparison across countries. When both crude and age-standardized rates remain low, it reflects genuine success in disease prevention and treatment rather than demographic effects. Japan’s CVD control success is linked to high-quality healthcare, dietary patterns, and public health strategies.